Catéter pleural permanente una opción para el manejo del derrame pleural maligno

Autores/as

DOI:

https://doi.org/10.35509/01239015.722

Palabras clave:

derrame pleural, derrame pleural maligno, cateter pleural, paliación

Resumen

Revisión narrativa sobre como el cáncer altera la fisiología de la pleura, como se estudia el derrame pleural maligno y como se puede brindar paliación manejo del paciente con derrame pleural con el catéter pleural permanente o tunelizado cuyo uso demuestra mayores beneficios en diferentes ámbitos clínicos, siendo utilizado principalmente para el tratamiento del derrame pleural tumoral recurrente pero también en algunos casos de derrame pleural benigno recurrente haciéndolo un recurso útil en cáncer avanzado.

Biografía del autor/a

Juan David Botero Bahamón, Pontifica Universidad Javeriana, Bogotá, Colombia

Medico, Universidad Pontifica Bolivariana; Medico Internista, Pontifica Universidad Javeriana; Fellow de Neumología, Pontifica Universidad Javeriana.

Javier Lasso, Hospital Universitario San Ignacio, Bogotá. Colombia

Medico Pontificia Universidad Javeriana

Medico Internista Pontifia Universidad Javeriana

Neumologo Pontifica Universidad Javeriana

Carlos Celis, Hospital Universitario San Ignacio, Bogotá. Colombia

Medico, Medico internista, neumologo.

Neumologo Hospital Universitario San Ignacio, Clinica de asma

Claudio Villaquiran Torres, Neumología, Hospital Universitario San Ignacio, Bogotá. Colombia

Medico y cirujano Pontificia Universidad Javeriana

Medico Internista Pontificia Universidad Javeriana

Neumologo Pontificia Universidad Javeriana

Actual Jefe de Neumología Hospital Universitario San Ignacio

July Torres, Hospital Universitario San Ignacio, Universidad Javeriana, Bogotá, Colombia

Medica y cirujana, Universidad el Rosario

Medica Internista, Pontificia Universidad Javeriana

Neumologa, Pontificia Universidad Javeriana

Neumologa Hospital Universitario de La Universidad Nacional de Colombia

Referencias bibliográficas

Skok K, Hladnik G, Grm A, Crnjac A. Malignant Pleural Effusion and Its Current Management: A Review. Med Kaunas Lith. 2019;55. https://doi.org/ 10.3390/medicina55080490

Rodrîguez-Panadero F, Borderas Naranjo F, López Mejîas J. Pleural metastatic tumours and effusions. Frequency and pathogenic mechanisms in a post-mortem series. Eur Respir J.1989;2:366-9.

Penz E, Watt KN, Hergott CA, Rahman NM, Psallidas I. Management of malignant pleural effusion: challenges and solutions. Cancer Manag Res. 2017;9:229-41. https://doi.org/10.2147/CMAR.S95663

Boshuizen RC, Vincent AD, van den Heuvel MM. Comparison of modified Borg scale and visual analog scale dyspnea scores in predicting re-intervention after drainage of malignant pleural effusion. Support Care Cancer Off J Multinatl Assoc Support Care Cancer. 2013;21:3109-16. https://doi.org/10.1007/s00520-013-1895-3

Tremblay A, Robbins S, Berthiaaume L. Natural History of Asymptomatic Pleural Effusions in Lung Cancer Patients. J Bronchol. 2007;14:98-100.

Smyrnios NA, Jederlinic PJ, Irwin RS. Pleural effusion in an asymptomatic patient. Spectrum and frequency of causes and management considerations. Chest.1990;97:192-6. https://doi.org/10.1378/chest.97.1.192

Grosu HB, Kazzaz F, Vakil E, Molina S, Ost D. Sensitivity of Initial Thoracentesis for Malignant Pleural Effusion Stratified by Tumor Type in Patients with Strong Evidence of Metastatic Disease. Respir Int Rev Thorac Dis. 2018;96:363-9. https://doi.org/10.1159/000490732

Miyoshi S, Sasada S, Izumo T, Matsumoto Y, Tsuchida T. Diagnostic Utility of Pleural Fluid Cell Block versus Pleural Biopsy Collected by Flex-Rigid Pleuroscopy for Malignant Pleural Disease: A Single Center Retrospective Analysis. PloS One. 2016;11:e0167186. https://doi.org/10.1371/journal.pone.0167186

Ferreiro L, Suárez-Antelo J, Valdés L. Pleural procedures in the management of malignant effusions. Ann Thorac Med. 2017;12:3-10. https://doi.org/10.4103/1817-1737.197762

Feller-Kopman DJ, Reddy CB, DeCamp MM, Diekemper RL, Gould MK, Henry T, et al. Management of Malignant Pleural Effusions. An Official ATS/STS/STR Clinical Practice Guideline. Am J Respir Crit Care Med. 2018;198:839-49. https://doi.org/10.1164/rccm.201807-1415ST

Negrini D, Moriondo A. Pleural function and lymphatics. Acta Physiol Oxf Engl. 2013;207:244-59. https://doi.org/10.1111/apha.12016

Charalampidis C, Youroukou A, Lazaridis G, Baka S, Mpoukovinas I, Karavasilis V, et al. Physiology of the pleural space. J Thorac Dis. febrero de 2015;7(Suppl 1):S33-37. https://doi.org/10.3978/j.issn.2072-1439.2014.12.48

Thomas R, Jenkins S, Eastwood PR, Lee YCG, Singh B. Physiology of breathlessness associated with pleural effusions. Curr Opin Pulm Med. 2015;21:338-45. https://doi.org/10.1097/MCP.0000000000000174

Light RW, Macgregor MI, Luchsinger PC, Ball WC. Pleural effusions: the diagnostic separation of transudates and exudates. Ann Intern Med. 1972;77:507-13. https://doi.org/10.7326/0003-4819-77-4-507

Wilcox ME, Chong CAKY, Stanbrook MB, Tricco AC, Wong C, Straus SE. Does this patient have an exudative pleural effusion? The Rational Clinical Examination systematic review. JAMA. 2014;311:2422-31. https://doi.org/10.1001/jama.2014.5552

Bielsa S, Porcel JM, Castellote J, Mas E, Esquerda A, Light RW. Solving the Light’s criteria misclassification rate of cardiac and hepatic transudates. Respirol Carlton Vic. 2012;17:721-6. https://doi.org/10.1111/j.1440-1843.2012.02155.x

Johnson L, Fakih HAM, Daouk S, Saleem S, Ataya A. Transudative pleural effusion of malignant etiology: Rare but real. Respir Med Case Rep. 2017;20:188-91. https://doi.org/10.1016/j.rmcr.2017.02.015

Sahn SA. Pleural diseases related to metastatic malignancies. Eur Respir J. 1997;10:1907-13. https://doi.org/10.1183/09031936.97.10081907

Karpathiou G, Mobarki M, Stachowicz ML, Hathroubi S, Patoir A, Tiffet O, et al. Pericardial and Pleural Metastases: Clinical, Histologic, and Molecular Differences. Ann Thorac Surg. 2018;106:872-9. https://doi.org/10.1016/j.athoracsur.2018.04.073

Veena A, Robert L, Phillipe A, Christian B, Peter G, Jeffrey H, et al. American Thoracic Society Guidelin.Management of Malignant Pleural Effusions Am J Respir Crit Care Med 2000; 162;1987-2001. https://doi.org/10.1164/ajrccm.162.5.ats8-00

Ferrer J, Roldán J, Teixidor J, Pallisa E, Gich I, Morell F. Predictors of pleural malignancy in patients with pleural effusion undergoing thoracoscopy. Chest. 2005;127:1017-22. https://doi.org/10.1378/chest.127.3.1017

Murthy P, Ekeke CN, Russell KL, Butler SC, Wang Y, Luketich JD, et al. Making cold malignant pleural effusions hot: driving novel immunotherapies. Oncoimmunology. 2019;8:e1554969. https://doi.org/10.1080/2162402X.2018.1554969

Stathopoulos GT. Translational advances in pleural malignancies. Respirol Carlton Vic. 2011;16:53-63. https://doi.org/10.1111/j.1440-1843.2010.01890.x

Walker S, Mercer R, Maskell N, Rahman NM. Malignant pleural effusion management: keeping the flood gates shut. Lancet Respir Med. 2020;8:609-18. https://doi.org/10.1016/S2213-2600(19)30373-X

Bibby AC, Dorn P, Psallidas I, Porcel JM, Janssen J, Froudarakis M, et al. ERS/EACTS statement on the management of malignant pleural effusions. Eur Respir J. 2018;52. https://doi.org/10.1183/13993003.00349-2018

Zamboni MM, da Silva CT, Baretta R, Cunha ET, Cardoso GP. Important prognostic factors for survival in patients with malignant pleural effusion. BMC Pulm Med. 2015;15:29. https://doi.org/10.1186/s12890-015-0025-z

Clive AO, Kahan BC, Hooper CE, Bhatnagar R, Morley AJ, Zahan-Evans N, et al. Predicting survival in malignant pleural effusion: development and validation of the LENT prognostic score. Thorax. 2014;69:1098-104. https://doi.org/10.1136/thoraxjnl-2014-205285

Pilling JE, Dusmet ME, Ladas G, Goldstraw P. Prognostic factors for survival after surgical palliation of malignant pleural effusion. J Thorac Oncol Off Publ Int Assoc Study Lung Cancer. 2010;5:1544-50. https://doi.org/10.1097/JTO.0b013e3181e95cb8

Abrao FC, de Abreu IRLB, Fogarolli M, Caxeiro G, Bezerra CBS, de Cerqueira Cesar FP, et al. Prognostic Factors of 30-Day Mortality After Palliative Procedures in Patients with Malignant Pleural Effusion. Ann Surg Oncol. 2015;22:4083-8. https://doi.org/10.1245/s10434-015-4491-6

Mercer R, Speck N, Jeffries H. J. Macready, N. Kanellakis, N. Maskell et al. Predictors of pleurodesis success. Abstract. ERS international congress París 2018. Available on https://www.ers-education.org/events/international-congress/paris-2018.aspx?idP=211008. https://doi.org/10.1111/resp.13755

Fysh ETH, Waterer GW, Kendall PA, Bremner PR, Dina S, Geelhoed E, et al. Indwelling pleural catheters reduce inpatient days over pleurodesis for malignant pleural effusion. Chest. 2012;142:394-400. https://doi.org/10.1378/chest.11-2657

Abrão FC, Abreu IRLB de, Cavalcanti MG, Pompa-Filho JFS. Use of indwelling pleural catheters for the definitive treatment of malignant pleural effusion. J Bras Pneumol Publicacao Of Soc Bras Pneumol E Tisilogia. 2017;43:14-7. https://doi.org/10.1590/S1806-37562016000000021

Bertolaccini L, Viti A, Gorla A, Terzi A. Home-management of malignant pleural effusion with an indwelling pleural catheter: ten years experience. Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol. 2012;38:1161-4. https://doi.org/10.1016/j.ejso.2012.08.021

Wong WM, Tam TC, Wong MK, Lui MM, Ip MS, Lam DC. Managing malignant pleural effusion with an indwelling pleural catheter: factors associated with spontaneous pleurodesis. Hong Kong Med J Xianggang Yi Xue Za Zhi. 2016;22:334-40. https://doi.org/10.12809/hkmj154673

Wahidi MM, Reddy C, Yarmus L, Feller-Kopman D, Musani A, Shepherd RW, et al. Randomized Trial of Pleural Fluid Drainage Frequency in Patients with Malignant Pleural Effusions. The ASAP Trial. Am J Respir Crit Care Med. 2017;195:1050-7. https://doi.org/10.1164/rccm.201607-1404OC

Lorenzo M-J, Modesto M, Pérez J, Bollo E, Cordovilla R, Muñoz M, et al. Quality-of-Life assessment in malignant pleural effusion treated with indwelling pleural catheter: a prospective study. Palliat Med. abril de 2014;28:326-34. https://doi.org/10.1177/0269216314521851

Sabur NF, Chee A, Stather DR, Maceachern P, Amjadi K, Hergott CA, et al. The impact of tunneled pleural catheters on the quality of life of patients with malignant pleural effusions. Respir Int Rev Thorac Dis. 2013;85:36-42. https://doi.org/10.1159/000342343

Gupta SS, Floudas CS, Chandra AB. A comparison between two types of indwelling pleural catheters for management of malignant pleural effusions. J Thorac Dis. 2018;10:2976-80. https://doi.org/10.21037/jtd.2018.05.57

Herlihy JP, Loyalka P, Gnananandh J, Gregoric ID, Dahlberg CGW, Kar B, et al. PleurX catheter for the management of refractory pleural effusions in congestive heart failure. Tex Heart Inst J. 2009;36:38-43.

Potechin R, Amjadi K, Srour N. Indwelling pleural catheters for pleural effusions associated with end-stage renal disease: a case series. Ther Adv Respir Dis. 2015;9:22-7. https://doi.org/10.1177/1753465814565353

Kniese C, Diab K, Ghabril M, Bosslet G. Indwelling Pleural Catheters in Hepatic Hydrothorax: A Single-Center Series of Outcomes and Complications. Chest. 2019;155:307-14. https://doi.org/10.1016/j.chest.2018.07.001

Thomas R, Fysh ETH, Smith NA, Lee P, Kwan BCH, Yap E, et al. Effect of an Indwelling Pleural Catheter vs Talc Pleurodesis on Hospitalization Days in Patients With Malignant Pleural Effusion: The AMPLE Randomized Clinical Trial. JAMA. 2017;318:1903-12. https://doi.org/10.1001/jama.2017.17426

Botana-Rial M, Ramos-Hernández C, Lojo-Rodríguez I, Represas-Represas C, Ruano-Raviña A, Leiro-Fernández V, et al. Cost-Effectiveness of Malignant Pleural Effusion with Indwelling Catheter: Systematic Review. J Palliat Med. 30; 2020. https://doi.org/10.1089/jpm.2020.0695

Shafiq M, Simkovich S, Hossen S, Feller-Kopman DJ. Indwelling Pleural Catheter Drainage Strategy for Malignant Effusion: A Cost-Effectiveness Analysis. Ann Am Thorac Soc. 2020;17:746-53. https://doi.org/10.1513/AnnalsATS.201908-615OC

Rendón-Ramírez E, Cedillo-Huerta H, Colunga-Pedraza P, Renpenning-Carrasco E, Mercado-Longoria R, González-Guerrero J, et al. An Inexpensive Way to Drain Malignant Effusions With Indwelling Pleural Catheters and Its Impact on Performance Status and Pleurodesis. Experience from a Tertiary Hospital in México. Open Respir Arch. 2020;2.

De Abreu IRLB, Bina Biazzotto AF, Santos MA, de Souza AAC, Abrão FC, Cavalcante MGC. The Low-Cost, Long-Term Indwelling Pleural Catheter (LunGO): An Inexpensive and Effective Alternative for the Management of Dyspnea Associated with Malignant Pleural Effusions. Respir Int Rev Thorac Dis. 2019;98:151-6. https://doi.org/10.1159/000498971

Mekhaiel E, Kashyap R, Mullon JJ, Maldonado F. Infections associated with tunnelled indwelling pleural catheters in patients undergoing chemotherapy. J Bronchol Interv Pulmonol. 2013;20:299-303. https://doi.org/10.1097/LBR.0000000000000001

Mitchell MA, Burkett A, Li P, Zhang T, Amjadi K. Effect of Chemotherapy on Removal of Indwelling Pleural Catheters in Breast Cancer Patients with Malignant Pleural Effusions. Respir Int Rev Thorac Dis. 2018;96:552-9. https://doi.org/10.1159/000491097

Morel A, Mishra E, Medley L, Rahman NM, Wrightson J, Talbot D, et al. Chemotherapy should not be withheld from patients with an indwelling pleural catheter for malignant pleural effusion. Thorax. 2011;66:448-9. https://doi.org/10.1136/thx.2009.133504

Hak CCW, Sivakumar P, Ahmed L. Safety of indwelling pleural catheter use in patients undergoing chemotherapy: a fiveyear retrospective evaluation. BMC Pulm Med. 2016;16:41. https://doi.org/10.1186/s12890-016-0203-7

Chalhoub M, Saqib A, Castellano M. Indwelling pleural catheters: complications and management strategies. J Thorac Dis. 2018;10:4659-66. https://doi.org/10.21037/jtd.2018.04.160

Thomas R, Roy B, Maldonado F, Lee YCG. Management of Malignant Pleural Effusions-What Is New. Semin

Respir Crit Care Med. 2019;40:323-39. https://doi.org/10.1055/s-0039-1698285

Tan C, Tien M, Lee C. Talc pleurodesis: It is not for everyone. Abstract, ERS international Congress; London 2016. Avaliable on https://erj.ersjournals.com/content/48/suppl_60/PA3390.

Olden AM, Holloway R. Treatment of malignant pleural effusion: PleuRx catheter or talc pleurodesis? A costeffectiveness analysis. J Palliat Med. 2010;13:59-65. https://doi.org/10.1089/jpm.2009.0220

Dipper A, Jones HE, Bhatnagar R, Preston NJ, Maskell N, Clive AO. Interventions for the management of malignant pleural effusions: a network meta-analysis. Cochrane Database Syst Rev. 2020;4:CD010529. https://doi.org/10.1002/14651858.CD010529.pub3

Roberts ME, Neville E, Berrisford RG, Antunes G, Ali NJ, BTS Pleural Disease Guideline Group. Management of a malignant pleural effusion: British Thoracic Society Pleural Disease Guideline 2010. Thorax. 2010;65 Suppl 2:ii32-40. https://doi.org/10.1136/thx.2010.136994

Efthymiou CA, Masudi T, Thorpe JAC, Papagiannopoulos K. Malignant pleural effusion in the presence of trapped lung. Five-year experience of PleurX tunnelled catheters. Interact Cardiovasc Thorac Surg. 2009;9:961-4. https://doi.org/10.1510/icvts.2009.211516

Warren WH, Kalimi R, Khodadadian LM, Kim AW. Management of malignant pleural effusions using the Pleur(x) catheter. Ann Thorac Surg. 2008;85:1049-55. https://doi.org/10.1016/j.athoracsur.2007.11.039

Gilbert CR, Lee HJ, Akulian JA, Hayes M, Ortiz R, Hashemi D, et al. A Quality Improvement Intervention to Reduce Indwelling Tunneled Pleural Catheter Infection Rates. Ann Am Thorac Soc. 2015;12:847-53. https://doi.org/10.1513/AnnalsATS.201411-511OC

Fysh ETH, Tremblay A, Feller-Kopman D, Mishra EK, Slade M, Garske L, et al. Clinical outcomes of indwelling pleural catheter-related pleural infections: an international multicenter study. Chest. 2013;144:1597-602. https://doi.org/10.1378/chest.12-3103

Lui MMS, Thomas R, Lee YCG. Complications of indwelling pleural catheter use and their management. BMJ Open Respir Res. 2016;3:e000123. https://doi.org/10.1136/bmjresp-2015-000123

Aapro M, Arends J, Bozzetti F, Fearon K, Grunberg SM, Herrstedt J, et al. Early recognition of malnutrition and cachexia in the cancer patient: a position paper of a European School of Oncology Task Force. Ann Oncol Off J Eur Soc Med Oncol. 2014;25:1492-9. https://doi.org/10.1093/annonc/mdu085

Jimenez CA, Mhatre AD, Martinez CH, Eapen GA, Onn A, Morice RC. Use of an indwelling pleural catheter for the management of recurrent chylothorax in patients with cancer. Chest. 2007;132:1584-90. https://doi.org/10.1378/chest.06-2141

Mitchell MA, Li P, Pease C, Hosseini S, Souza C, Zhang T, et al. Catheter Tract Metastasis in Mesothelioma Patients with Indwelling Pleural Catheters: A Retrospective Cohort Study. Respir Int Rev Thorac Dis. 2019;97:428-35. https://doi.org/10.1159/000494500

Thomas R, Budgeon CA, Kuok YJ, Read C, Fysh ETH, Bydder S, et al. Catheter tract metastasis associated with indwelling pleural catheters. Chest. 2014;146:557-62. https://doi.org/10.1378/chest.13-3057

Wrightson JM, Fysh E, Maskell NA, Lee YCG. Risk reduction in pleural procedures: sonography, simulation and supervision. Curr Opin Pulm Med. 2010;16:340-50. https://doi.org/10.1097/MCP.0b013e32833a233b

Wilshire CL, Louie BE, Aye RW, Farivar AS, Vallières E, Gorden JA. Safety and Efficacy of Fibrinolytic Therapy in Restoring Function of an Obstructed Tunneled Pleural Catheter. Ann Am Thorac Soc. 2015;12:1317-22. https://doi.org/10.1513/AnnalsATS.201503-182OC

Vial MR, Ost DE, Eapen GA, Jimenez CA, Morice RC, O’Connell O, et al. Intrapleural Fibrinolytic Therapy in Patients With Nondraining Indwelling Pleural Catheters. J Bronchol Interv Pulmonol. 2016;23:98-105. https://doi.org/10.1097/LBR.0000000000000265

Thomas R, Piccolo F, Miller D, MacEachern PR, Chee AC, Huseini T, et al. Intrapleural Fibrinolysis for the Treatment of Indwelling Pleural Catheter-Related Symptomatic Loculations: A Multicenter Observational Study. Chest. 2015;148:746-51. https://doi.org/10.1378/chest.14-2401

Fysh ETH, Wrightson JM, Lee YCG, Rahman NM. Fractured indwelling pleural catheters. Chest. 2012;141:1090-4. https://doi.org/10.1378/chest.11-0724

Cómo citar

[1]
Botero Bahamon, J.D., Lasso Apraez, J.I., Celis Preciado, C.A., Villaquiran Torres, C. y Torres, J.V. 2021. Catéter pleural permanente una opción para el manejo del derrame pleural maligno. Revista Colombiana de Cancerología. 26, 1 (jul. 2021), 14–21. DOI:https://doi.org/10.35509/01239015.722.

Descargas

Los datos de descargas todavía no están disponibles.

Descargas

Publicado

2021-07-15

Número

Sección

Artículos de revisión